According to Relay Therapeutics's latest financial reports the company has a price-to-book ratio of 1.15.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.80 | -5.05% |
2022-12-31 | 1.90 | -48.57% |
2021-12-31 | 3.70 | -24.57% |
2020-12-31 | 4.90 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.66 | 131.55% | ๐บ๐ธ USA |